1887
Rapid communications Open Access
Like 0
This item has no PDF Download

Abstract

Surveillance of the antiviral susceptibility of influenza viruses circulating in Europe has been established since 2004 through the European Union-funded European Surveillance Network for Vigilance against Viral Resistance (VIRGIL), in collaboration with the European Influenza Surveillance Scheme (EISS), the World Health Organization (WHO) and national influenza centres. Results from analysis of early winter (November 2007 - January 2008) A(H1N1) virus isolates has revealed that a significant proportion, approximately 14% of these European strains (see Table), are resistant to oseltamivir (Tamiflu), the most widely used anti-influenza drug, but retain sensitivity to zanamivir (Relenza) and amantadine/rimantadine. .

Loading

Article metrics loading...

/content/10.2807/ese.13.05.08026-en
2008-01-31
2017-10-18
http://instance.metastore.ingenta.com/content/10.2807/ese.13.05.08026-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/13/5/art08026-en.htm?itemId=/content/10.2807/ese.13.05.08026-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error